SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-033783
Filing Date
2024-04-17
Accepted
2024-04-17 16:00:20
Documents
3
Period of Report
2024-04-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0204065-6k_clear.htm 6-K 11475
2 PRESS RELEASE TITLED: "CLEARMIND MEDICINE ANNOUNCES EXCLUSIVE LICENSING AGREEMEN ea020406502ex99-1_clear.htm EX-99.1 10593
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1669
  Complete submission text file 0001213900-24-033783.txt   25582
Mailing Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5
Business Address 101-1220 WEST 6TH AVENUE VANCOUVER, BRITISH COLUMBIA Z4 V6H1A5 972-54-5704749
Clearmind Medicine Inc. (Filer) CIK: 0001892500 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 6-K | Act: 34 | File No.: 001-41557 | Film No.: 24850909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)